Correlation of p53 mutations in ThinPrep-processed fine needle breast aspirates with surgically resected breast cancers

Modern Pathology

Volumn 13, Issue 11, 2000, Pages 1173-1179

  Pollett, Aaron ^a   Bédard, Yvan C ^a   Li, Shu Qiu ^a   Rohan, Tom ^b   Kandel, Rita ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Breast cancer; Fine needle aspiration; P53 mutation; ThinPrep

Indexed keywords

DNA; PROTEIN P53;

AMINO ACID SUBSTITUTION; ARTICLE; ASPIRATION BIOPSY; BASE PAIRING; BREAST CANCER; CODON; CONTROLLED STUDY; DNA DETERMINATION; DNA POLYMORPHISM; EXON; GENE MUTATION; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROGNOSIS; SEQUENCE ANALYSIS;

EID: 0033695870     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880216     Document Type: Article

References (42)

1. The p53 tumour suppressor gene
2. p53-Dependent apoptosis modulates the cytotoxicity of anticancer agents
3. Expression of the mutated p53 tumor suppressor protein and its molecular and biochemical characterization in multidrug resistant MCF- 7/Adr human breast cancer cells
4. Specific P53 mutations are associated with de novo resistance to doxorubicin in breast cancer patients
5. TP53 and MYC gene alterations independently predict poor prognosis in breast cancer patients
6. Mutations in residues of TP53 that directly contact DNA predict poor outcome in human primary breast cancer
7. The p53 gene in breast cancer: Prognostic value of complementary DNA sequencing versus immunohistochemistry
8. Prognostic and predictive value of p53 and p21 in breast cancer
9. Somatic mutations in the p53 gene and prognosis in breast cancer: A meta-analysis
10. The uniform approach to breast fine-needle aspiration biopsy. National Cancer Institute Fine-Needle Aspiration of Breast Workshop Subcommittees
11. Techniques and results of aspiration cytology for diagnosis of benign and malignant diseases of the breast
12. Breast fine-needle aspiration. A comparison of ThinPrep and conventional smears
13. Estrogen and progesterone receptor contents in ThinPrep-processed fine-needle aspirates of breast
14. Immunocytochemical staining on ThinPrep processed smears
15. Polymerase chain reaction-based detection of clonality as a non-morphologic diagnostic tool for fine-needle aspiration of the breast
16. Characterization of RNA in cytologic samples preserved in a methanol-based collection solution
17. Cervical specimens collected in liquid buffer are suitable for both cytologic screening and ancillary human papillomavirus testing
18. Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: Experience from a large study with long-term follow-up
19. Cyclin D1 gene amplification and protein expression in benign breast disease and breast carcinoma
20. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction
21. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis
22. IARC Database of p53 gene mutations in human tumors and cell lines: Updated compilation, revised formats and new visualisation tools
23. c-erb B-2 and p53 expression in breast cancer fine needle aspirates
24. p53 Protein expression in fine-needle aspirates of breast cancer: An immunocytochemical assay for identifying high-grade ductal carcinomas
25. Cytological evaluation of biological prognostic markers from primary breast carcinomas
26. A high frequency of sequence alterations is due to formalin fixation of archival specimens
27. Mutations in BRCA1 from fixed, paraffin-embedded tissue can be artifacts of preservation
28. DNA template as a source of artifact in the detection of p53 gene mutations using archived tissue
29. Correlation between p53 mutations and antibody staining in breast carcinoma
30. p53 Gene mutations in breast cancers in Midwestern US women: Null as well as missense-type mutations are associated with poor prognosis
31. Mutations in the p53 gene in primary human breast cancers
32. Detection of p53 gene mutations in fine-needle aspiration biopsied breast cancer specimens: Correlations with nuclear p53 accumulation and tumor DNA aneuploidy patterns
33. Detection of TP53 mutation, loss of heterozygosity and DNA content in fine-needle aspirates of breast carcinoma
34. Functional studies of a germ-line polymorphism at codon 47 within the p53 gene
35. p53 Polymorphisms and haplotypes in breast cancer
36. Polymorphism at codon 213 within the p53 gene
37. p53 Gene mutations and steroid receptor status in breast cancer. Clinicopathologic correlations and prognostic assessment
38. Detection of p53 gene mutation by rapid PCR-SSCP and its association with poor survival in breast cancer
39. Expression of proliferating cell nuclear antigen, Ki-67 antigen, estrogen receptor protein, and tumor suppressor p53 gene in cytologic samples of breast cancer: An immunochemical study with clinical, pathobiological, and histologic correlations
40. p53 Protein detected by immunohistochemical staining is not always mutant
41. p53 Immunohistochemical analysis in breast cancer with four monoclonal antibodies: Comparison of staining and PCR-SSCP results